BGMD has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BGMD has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BG Medicine's gross profit for the three months ended in Dec. 2015 was $0.21 Mil. BG Medicine's gross profit for the trailing twelve months (TTM) ended in Dec. 2015 was $1.06 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. BG Medicine's gross profit for the three months ended in Dec. 2015 was $0.21 Mil. BG Medicine's Revenue for the three months ended in Dec. 2015 was $0.29 Mil. Therefore, BG Medicine's Gross Margin % for the quarter that ended in Dec. 2015 was 71.72%.
BG Medicine had a gross margin of 71.72% for the quarter that ended in Dec. 2015 => Durable competitive advantage
The historical data trend for BG Medicine's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BG Medicine Annual Data | |||||||||||||||||||||
Trend | Dec05 | Dec06 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec13 | Dec14 | Dec15 | |||||||||||
Gross Profit | Get a 7-Day Free Trial | 1.02 | 1.86 | 2.68 | 1.83 | 1.06 |
BG Medicine Quarterly Data | ||||||||||||||||||||
Mar11 | Jun11 | Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Dec13 | Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | |
Gross Profit | Get a 7-Day Free Trial | 0.36 | 0.29 | 0.33 | 0.23 | 0.21 |
For the Medical Instruments & Supplies subindustry, BG Medicine's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's Gross Profit distribution charts can be found below:
* The bar in red indicates where BG Medicine's Gross Profit falls into.
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
BG Medicine's Gross Profit for the fiscal year that ended in Dec. 2015 is calculated as
Gross Profit (A: Dec. 2015 ) | = | Revenue | - | Cost of Goods Sold |
= | 1.566 | - | 0.505 | |
= | 1.06 |
BG Medicine's Gross Profit for the quarter that ended in Dec. 2015 is calculated as
Gross Profit (Q: Dec. 2015 ) | = | Revenue | - | Cost of Goods Sold |
= | 0.29 | - | 0.082 | |
= | 0.21 |
Gross Profit for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.06 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
BG Medicine's Gross Margin % for the quarter that ended in Dec. 2015 is calculated as
Gross Margin % (Q: Dec. 2015 ) | = | Gross Profit (Q: Dec. 2015 ) | / | Revenue (Q: Dec. 2015 ) |
= | (Revenue - Cost of Goods Sold) | / | Revenue | |
= | 0.21 | / | 0.29 | |
= | 71.72 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BG Medicine (OTCPK:BGMD) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BG Medicine had a gross margin of 71.72% for the quarter that ended in Dec. 2015 => Durable competitive advantage
Thank you for viewing the detailed overview of BG Medicine's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeffrey R Luber | director | 100 CAMPUS DRIVE, C/O EXACT SCIENCES CORP, MARLBOROUGH MA 01752 |
Noubar Afeyan | director, 10 percent owner | C/O FLAGSHIP PIONEERING, INC., 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Stelios Papadopoulos | director | 3 SOMERSET DRIVE SOUTH, GREAT NECK NY 11020 |
Harry W Wilcox | director | ONE KENDALL SQ, BLDG 700, CAMBRIDGE MA 02139 |
Agtc Partners, L.p. | 10 percent owner | C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 |
Newcogen Group, Inc. | 10 percent owner | C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 |
Applied Genomic Technology Capital Fund Lp | 10 percent owner | C/O FLAGSHIP VENTURES ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 |
Flagship Pioneering Inc. | 10 percent owner | 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Agtc Advisors Fund Lp | 10 percent owner | ONE MEMORIAL DRIVE 7TH FLOOR CAMBRIDGE MA 02142 |
Kania Edwin M Jr | 10 percent owner | |
Flagship Ventures Fund 2007, L.p. | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142 |
Flagship Ventures 2007 General Partner Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Brian S Posner | director | 14 CAMBRIDGE CENTER, CAMBRIDGE MA 02142 |
Stephane Bancel | director | 320 BENT STREET, CAMBRIDGE MA 02141 |
Harris Timothy J.r. | director | C/O BG MEDICINE, 610 LINCOLN STREET NORTH, WALTHAM MA 02451 |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.